Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Moderna
MRNA
|
$1.79B |
| 2 |
Illumina
ILMN
|
$780M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$727M |
| 4 |
DexCom
DXCM
|
$453M |
| 5 |
Netflix
NFLX
|
$384M |
Top Sells
| 1 |
Tesla
TSLA
|
$5.22B |
| 2 |
Amazon
AMZN
|
$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
$610M |
| 4 |
Zillow
Z
|
$470M |
| 5 |
Ionis Pharmaceuticals
IONS
|
$271M |
Sector Composition
| 1 | Consumer Discretionary | 37.93% |
| 2 | Technology | 16.18% |
| 3 | Healthcare | 15.43% |
| 4 | Communication Services | 14.41% |
| 5 | Financials | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
FirstCash
FCFS
$6.69B
| $20.5M | 0.01% |
+293,000
| New | +$20.5M |
|
|
UBX
202
DELISTED
Unity Biotechnology
UBX
| $19.9M | 0.01% |
380,301
| – | – |
|
203
Royal Caribbean
RCL
$97.8B
| $18.8M | 0.01% |
+252,000
| New | +$18.8M |
|
204
Stratasys
SSYS
$866M
| $18.6M | 0.01% |
896,712
-1,358
| -0.2% | -$28.1K |
|
|
OCFT
205
OneConnect Financial Technology
OCFT
$277M
| $18.5M | 0.01% |
+93,845
| New | +$18.5M |
|
|
API
206
Agora
API
$299M
| $17.1M | 0.01% |
433,200
+33,200
| +8% | +$1.31M |
|
207
Visa
V
$681B
| $15.8M | 0.01% |
72,337
-9,025
| -11% | -$1.97M |
|
208
Align Technology
ALGN
$9.76B
| $15.7M | 0.01% |
29,346
-4,335
| -13% | -$2.32M |
|
209
American Superconductor
AMSC
$2.19B
| $15.2M | 0.01% |
650,300
+133,030
| +26% | +$3.12M |
|
|
NCNA
210
NuCana
NCNA
$5.46M
| $14.9M | 0.01% |
664
+54
| +9% | +$1.21M |
|
211
TJX Companies
TJX
$157B
| $14.7M | 0.01% |
215,250
-18,998
| -8% | -$1.3M |
|
|
NBIS
212
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.5B
| $14.3M | 0.01% |
+205,414
| New | +$14.3M |
|
|
BNFT
213
DELISTED
Benefitfocus, Inc.
BNFT
| $13.7M | 0.01% |
947,612
-10,389
| -1% | -$150K |
|
|
KDNY
214
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $13.4M | 0.01% |
844,684
-8,512
| -1% | -$135K |
|
215
Cooper Companies
COO
$13.5B
| $13M | 0.01% |
+142,800
| New | +$13M |
|
216
Invesco Senior Income Trust
VVR
$555M
| $12.7M | 0.01% |
3,195,695
| – | – |
|
217
Sherwin-Williams
SHW
$91.2B
| $12.2M | 0.01% |
49,893
-7,344
| -13% | -$1.8M |
|
218
Lindblad Expeditions
LIND
$793M
| $12M | 0.01% |
700,000
| – | – |
|
219
Verisk Analytics
VRSK
$37.7B
| $11.9M | 0.01% |
57,521
-8,665
| -13% | -$1.8M |
|
220
StoneCo
STNE
$4.42B
| $10.8M | 0.01% |
128,512
+1,424
| +1% | +$120K |
|
221
HUTCHMED
HCM
$2.55B
| $9.41M | 0.01% |
294,023
+22,416
| +8% | +$718K |
|
222
M&T Bank
MTB
$31.6B
| $9.3M | 0.01% |
73,026
-11,554
| -14% | -$1.47M |
|
223
BlackRock Floating Rate Income Trust
BGT
$317M
| $9.25M | 0.01% |
784,230
| – | – |
|
224
BridgeBio Pharma
BBIO
$9.91B
| $8.43M | ﹤0.01% |
118,532
+58,063
| +96% | +$4.13M |
|
225
Masimo
MASI
$7.77B
| $8.42M | ﹤0.01% |
31,367
+17,731
| +130% | +$4.76M |
|